| Latest Forum Topics / Clearbridge Last:0.002 -- |
 Post Reply
|
|
Medical Stock - Strong Shareholders
|
|||||
|
WBdisciple
Elite |
16-Jul-2020 14:45
|
||||
|
x 0
x 0 Alert Admin |
Really old article but it captures the leadership and foresight of Jeremy Yee (when he was CEO at Cordlife) https://www.forbes.com/sites/forbesasia/2015/06/24/cordlife-harvests-stem-cells-of-newborns-in-case-of-a-rare-disease/#abbccda43dca Cordlife Harvests Stem Cells Of Newborns In Case Of A Rare Disease This story appears in the July 2015 issue of Forbes Asia. Subscribe to Forbes Asia By Jane A. Peterson Walking down a hallway at the headquarters of Singapore health care company Cordlife, Chief Executive Jeremy Yee points to plaques commemorating 18 successful stem-cell infusions over its 14-year history. Georgia Conn' s cerebral palsy has improved after getting blood from her own umbilical cord when she was 2 years old. One 16-year-old is now in remission from leukemia, thanks to receiving his sister' s cord blood. " The odds of fighting off disease in a family are much higher if you store your own cord blood," says Yee. " Our strategy is to empower everyone to store." Cordlife operates cord-blood banks in five countries and rallies expectant parents with the emotive tagline, " one chance, one choice." It' s like an insurance policy against a rare disease: The stem cells derived from the blood are used in transplants to combat certain types of cancer and blood disorders. But customers are looking beyond current medical uses as advances in stem-cell therapy continue apace. Researchers hope that one day cord blood will be used for a host of other conditions, such as diabetes, heart disease and stroke. " Our role as a custodian is very much like a bank," says cofounder Ho Choon Hou, a principal at Southern Capital Group, a Singapore private equity firm. Ho also chairs Cordlife' s board. In Singapore new parents can choose to have their child' s cord-blood stem cells stored for 21 years under a $4,450 plan that also includes collection and processing. Storing the umbilical-cord lining costs an additional $4,450. The plans can be renewed once the child reaches adulthood. Banking umbilical-cord blood has caught fire in Asia, and Cordlife is well-positioned to cash in. The company boasts more than 100,000 customers and 700 employees for the region' s largest network of cord-blood banks. Singapore and Hong Kong are its most developed markets, with India, Indonesia and the Philippines quickly advancing. It also has a stake in Malaysia' s StemLife Bhd., which gives the company indirect access to Thai StemLife. Investors are piling in. Cordlife' s shares on the Singapore Exchange are up 25% this year, and analysts continue to rate the company a buy. Net profits more than doubled to $24.2 million for the year ended June 30, 2014. Analysts forecast lower net profits for the year ended last month but also a 13% rise in revenue, to $43 million. With this performance Cordlife debuts on our list of the 200 best listed companies in the Asia-Pacific region with under $1 billion in annual revenue. The business has its skeptics, however. Several government health agencies and doctors' associations in the West doubt that storing cord blood is a good way for parents to spend their money. The U.K.' s National Health Service cautions that the " probability of an average child requiring a transplant of their own stem cells before the age of 20 is estimated at between one in 5,000 and one in 20,000." For leukemia, it states, the use of a child' s own cord blood is " extremely unlikely." Intent on driving down costs as the business scales up, Yee champions a no-frills operation. An energetic, 45-year-old trained accountant, he' s Cordlife' s " longest surviving employee" --he joined in 2002. His own small office is tucked in among a hive of 110 employees on the sixth floor of a spartan building in the Yishun district. Steps from his office Yee peers through a window overlooking the lab. Here no expense is spared. Twice a day technicians receive deliveries of cord blood from hospitals around Singapore. They cull the maximum number of adult stem cells from each specimen, placing the CryoBags--marked and sealed--inside one of 15 temperature-controlled metal tanks, where they remain for the duration of the plan. Yee says the room could take 35 more. Similar operations exist across Cordlife' s Asian network. In India, where the charge for storing cord blood is far lower than in Singapore--$860 for an 18-year policy--Cordlife stores blood in Kolkata, has service centers in 42 cities and faces stiff competition. " Currently India is the largest contributor of new clients, though margins are lower," explains Yee, noting that volume jumped 50% in the fiscal year just ended. To capture more market share in India, Cordlife launched a pricey advertising campaign last year. While that hurt the bottom line, Yee believes that the awareness of parents required a jump start. Analysts liked the move. " It' s a one-off shot," says Conrad Werner at Macquarie Capital Securities. " Make a blitz and reap the reward. Next year we forecast a 46% jump in net profits." This year Cordlife agreed to sell its stake in the Chinese cord-blood bank operator CCBC, mainly because that company may be taken private. The sale is expected to generate net proceeds of $65 million, money that could help Cordlife build a business in China from the ground up: " We will start organically now in China, licensing technologies to hospitals and launching new screening services," says Yee. " We hope it will be a huge share of our revenue stream." Though Cordlife is now well-established, its startup days in 2001 were tough. Singaporeans had to be persuaded to save their children' s blood and to pay top dollar to do so. The venture was the brainchild of entrepreneur Steven Fang, a Singaporean who is no longer with the company. Fang sought venture capital funding for an Asian version of New York' s then-nine-year-old government cord-blood bank, while Ho focused on talking to regulators and doctors. In those early days the 21-year plan was pricier, but Cordlife still managed to sign up between 20 and 30 new mothers every month, stressing its promise of the highest-quality storage possible and its American Association of Blood Banks accreditation. " Our drive to transparency and [good] governance was key for us," recounts Ho, adding that this paved the way for the company to go public in 2012. Western parents rely less on private-sector cord-blood banks than do Asians. In the U.S. and Europe market-penetration rates for private banks hover at just 5% of all live births in Singapore it' s 22%, the lion' s share going to Cordlife rather than to its two competitors, while government banks get just a tiny percentage of the rest. " Asian parents invest an enormous amount in their children," says Ho, noting that Cordlife customers are the same ones who shower their offspring with extra schooling and extracurricular activities. So far the children of 18 customers--the 18 on the plaques--have had to use their stored cord blood. In India, Indonesia and the Philippines penetration rates are under 1%. However, analysts predict that they will rise as parents' awareness--and ability to pay--ratchets up. Cordlife' s " addressable sweet spot" is households with annual incomes of at least $50,000, ?according to Werner at Macquarie. For now Cordlife will hold off on opening offices and banks in more countries, choosing instead to build its key storage business in its existing markets and expand its range of services. But the company does want to sell more services to doctors and hospitals in other countries, including China. Yee cites plans to roll out at least five new mother/child products and services, which will focus on children up to age 7 among them, MetaScreen, a test of infants' urine that detects metabolic disorders. " I used to be afraid of the share price," admits Yee, " but after soul-searching I realized that is not the way. My endgame is to satisfy shareholders and be value-adding to humankind. I' m hot about that." |
||||
| Useful To Me Not Useful To Me | |||||
|
xKaiseRx
Veteran |
16-Jul-2020 13:32
|
||||
|
x 0
x 0 Alert Admin |
Die even harder
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
hotelgrand
Master |
16-Jul-2020 13:08
|
||||
|
x 0
x 0 Alert Admin |
becoz bought high 35cts right? loss making co...can multi bagger meh? philip secuirities say so??
|
||||
| Useful To Me Not Useful To Me | |||||
|
imma55
Member |
16-Jul-2020 11:54
|
||||
|
x 0
x 0 Alert Admin |
Thanks for the info
|
||||
| Useful To Me Not Useful To Me | |||||
|
Acidrxz
Member |
16-Jul-2020 10:52
|
||||
|
x 0
x 0 Alert Admin |
They revise alrdy chk sgx clearbridge....is half yearly...next results announcement only in NOV 2020
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
Trader130
Supreme |
16-Jul-2020 09:51
|
||||
|
x 0
x 0 Alert Admin |
Quarterly
|
||||
| Useful To Me Not Useful To Me | |||||
|
imma55
Member |
15-Jul-2020 19:53
|
||||
|
x 0
x 0 Alert Admin |
Any idea CB is half or quarterly earnings? | ||||
| Useful To Me Not Useful To Me | |||||
|
Trader130
Supreme |
15-Jul-2020 17:56
|
||||
|
x 0
x 0 Alert Admin |
Do not contra even good news ... There might be major BB looking to skim out juicy from the one who gamble .. Pay with cash if u think short term investment is sound .. Trade with common sense
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
Zerocool888
Master |
15-Jul-2020 14:27
|
||||
|
x 0
x 0 Alert Admin |
We can predict how CB behaves. 1) No good news - price stagnant and maybe drop a little. 2) Some good news - price stable and goes up a little 3) Good news - price goes up but contra players comes in wreck the stability of this stock. If it stays now on the range of 195-200 today, expect it to go up to 210-215 the next few days before dropping back to 190-195. And yes it' s really long term although it' s penny stock.
|
||||
| Useful To Me Not Useful To Me | |||||
|
Laurenpanna
Veteran |
15-Jul-2020 14:11
|
||||
|
x 0
x 0 Alert Admin |
this stock is going to be my long term hold for sure... hahahaha | ||||
| Useful To Me Not Useful To Me | |||||
|
eric998
Supreme |
15-Jul-2020 11:47
|
||||
|
x 0
x 0 Alert Admin |
missed the good deal.. HUAT!
|
||||
| Useful To Me Not Useful To Me | |||||
|
Zerocool888
Master |
15-Jul-2020 11:43
|
||||
|
x 0
x 0 Alert Admin |
SPOT ON!!! So that' s why whoever purchase CB have to long mid to long term.
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
wehuattogether88
Supreme |
15-Jul-2020 11:40
|
||||
|
x 0
x 0 Alert Admin |
Do not contra on CB as nobody knows when it will go Up or turn the other way..
|
||||
| Useful To Me Not Useful To Me | |||||
|
Zerocool888
Master |
15-Jul-2020 11:32
|
||||
|
x 0
x 0 Alert Admin |
I am very very sure some players got burn on Medtech the last 2 days. Those who greedy that went in at 80-90c and thinking it will go up $2.00-$3.00, will either have to hold on or sell at a lost, especially those contra players. Again, in my previous post before Medtech took a dive I did mention most big time contra players target cheap penny stock. Once they hit their target, it will be a big sell off. Never chase after a stock which keeps going up. I learn my painful lesson when i started investing 20 years ago. The stock went up too high without much correction. When it tried to correct, it was already too late. Actually it' s the same with CB which went up to 350 which plenty of players think it will go up to 50c but it did not BUT this stock will slowly go up but at a gradual phase. So I believe there are still pleny of players are stuck with CB on price at 300-350 at high number of lots. If you hold long enough for 1-2 years at least......it will eventually see it grow when their core business resume at 100%. At the moment, most Medical Stocks price are downtrend.......but if CB can maintain it' s momentum, it will be good for all of us who are still holding on. |
||||
| Useful To Me Not Useful To Me | |||||
|
trademaster
Supreme |
15-Jul-2020 11:07
|
||||
|
x 0
x 0 Alert Admin |
Lol, who panic sell below 185, now above 190 liao
|
||||
| Useful To Me Not Useful To Me | |||||
|
Zerocool888
Master |
15-Jul-2020 11:01
|
||||
|
x 0
x 0 Alert Admin |
By looking at the moment, it will hover between 188-190 if there are no big sell. Predicting a closing of 195-200 if Bio don' t do crazy again.....hahaha! Heavy q at 205-210. |
||||
| Useful To Me Not Useful To Me | |||||
|
wehuattogether88
Supreme |
15-Jul-2020 10:42
|
||||
|
x 0
x 0 Alert Admin |
Recovering slowly. | ||||
| Useful To Me Not Useful To Me | |||||
|
nissan
Member |
15-Jul-2020 10:17
|
||||
|
x 0
x 0 Alert Admin |
what is the next support? | ||||
| Useful To Me Not Useful To Me | |||||
|
Sg2022yu
Veteran |
15-Jul-2020 10:17
|
||||
|
x 0
x 0 Alert Admin |
Sold at .199 cover back at 189... i will cont Long then~ finally grab a chance to lower my avg Long..
|
||||
| Useful To Me Not Useful To Me | |||||
|
Zerocool888
Master |
15-Jul-2020 10:13
|
||||
|
x 0
x 0 Alert Admin |
Most probably will lose steam as usual......hahahahaha.......
|
||||
| Useful To Me Not Useful To Me | |||||